Urothelial Carcinoma of the Renal Pelvis

Slide 1 · Urothelial Carcinoma

of the Renal Pelvis

Pathology: origin • morphology • clinical correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Localize the tumor to collecting-system urothelium rather than renal parenchyma.

Recognize papillary, flat in situ, and invasive urothelial patterns.

Explain hematuria, obstruction, multifocality, and prognostic implications.

Schematic

Anatomy

Morphology

Clinical effects

Slide 3 · Renal pelvis: An epithelial rather than parenchymal origin

The renal pelvis receives urine draining from the calyces.

Its urothelial lining is continuous with ureter and bladder.

A renal-pelvis urothelial tumor begins at this luminal epithelial surface.

Schematic

Parenchyma

Pelvis

Ureter

Slide 4 · A continuous urothelial compartment

Renal pelvis, ureters, bladder, and most of the urethra share urothelium.

A lesion at one site can have histologic counterparts at another.

This explains why renal-pelvis tumors are interpreted with lower-tract pathology.

Schematic

Renal pelvis

Ureter

Bladder

Multiple epithelial sites; Not three renal masses

Slide 5 · Normal urothelium: Layered and specialized

Urothelium is normally several cell layers thick.

Large superficial umbrella cells form a differentiated surface layer.

The epithelium rests on a basement membrane above the lamina propria.

Schematic

Basement membrane

Lumen / umbrella-cell surface

Slide 6 · The basement membrane defines noninvasion

Cytologic malignancy can be confined to the epithelial compartment.

Crossing the basement membrane creates stromal invasion.

Architectural grade and depth of invasion answer different questions.

Schematic

Noninvasive

Basement membrane intact

Invasive

Epithelial nests beneath BM

Slide 7 · Renal-pelvis tumors constitute a distinct renal group

Approximately 5%–10% of primary renal tumors to pelvic urothelium.

This estimate concerns origin within the kidney, not all urothelial carcinomas.

Renal cell carcinoma instead arises from renal epithelial parenchyma.

Schematic

5%–10%

Of primary renal tumors arise from pelvic urothelium (Robbins)

Slide 8 · Renal cell carcinoma versus pelvic urothelial carcinoma

Renal cell carcinoma arises in the renal parenchyma.

Pelvic urothelial carcinoma arises at the collecting-system lining.

A mass in the kidney must be located before its morphology is interpreted.

Schematic

Renal parenchyma → RCC

Collecting-system lining → UC

Slide 9 · The clinical spectrum is broader than invasive cancer

Papillomas occupy the benign end of the urothelial lesion spectrum.

Noninvasive papillary carcinomas show malignant cytology without stromal invasion.

Invasive urothelial carcinoma extends beyond the epithelial compartment.

Schematic

Papilloma

Noninvasive carcinoma

Invasive carcinoma

Slide 10 · Two broad noninvasive pathways precede invasion

One precursor category is a papillary urothelial neoplasm.

The other is flat urothelial carcinoma in situ (CIS).

Both are described in bladder pathology and may occur throughout urothelium.

Schematic

Papillary precursor

Noninvasive disease

Potential invasion

Slide 11 · Papillary growth projects into the lumen

Exophytic papillary lesions form fronds with fibrovascular cores.

The epithelial lining may be bland, mildly atypical, or markedly atypical.

Papillary configuration alone does not establish grade or invasion.

Schematic

Papillary epithelial surface

Fibrovascular core

Slide 12 · Flat carcinoma in situ lacks an exophytic mass

CIS is cytologically malignant but confined to the urothelium.

It may occupy a flat mucosal surface rather than form a discrete tumor.

A grossly inconspicuous lining therefore can contain malignant epithelium.

Schematic

Basement membrane

Cytologic atypia within urothelium

Slide 13 · WHO 2022: Flat noninvasive lesions

Urothelial dysplasia is listed among flat lesions.

Urothelial carcinoma in situ is the malignant flat noninvasive category.

The architecture remains flat; Invasion is not part of the diagnosis of CIS.

Schematic

Dysplasia

Flat carcinoma in situ

Slide 14 · WHO 2022: Exophytic noninvasive lesions

Papilloma and papillary urothelial neoplasm of low malignant potential (PUNLMP).

Papillary urothelial carcinoma, low grade.

Papillary urothelial carcinoma, high grade.

Schematic

Papilloma / PUNLMP

Low-grade carcinoma

High-grade carcinoma

Slide 15 · Exophytic papilloma: A delicate benign papilla

Typically a small lesion with slender papillary stalks.

Each fibrovascular core is lined by near-normal urothelium.

Recurrence and progression are rare in the bladder descriptions.

Schematic

Papillary epithelial surface

Fibrovascular core

Slide 16 · Inverted papilloma may simulate invasion

Bland urothelial cords extend downward into the lamina propria.

The lesion is architecturally endophytic rather than exophytic.

Its cytologic blandness distinguishes it from infiltrative carcinoma.

Schematic

Bland urothelial cords extend downward

Slide 17 · PUNLMP: Thicker urothelium without overt high grade

A papillary lesion resembles papilloma but has increased epithelial thickness.

Cell density is increased while severe disorganization is absent.

Recurrences are possible; Higher-grade progression is described as rare.

Schematic

Thickened papillary urothelial covering

Fibrovascular core

Slide 18 · Low-grade papillary carcinoma preserves organization

Cells remain cohesive with relatively even spacing and polarity.

Nuclear size and shape vary slightly; Scattered hyperchromatic nuclei occur.

Mitoses are infrequent and tend to be basal.

Schematic

Polarity retained · mild variation · cohesion

Slide 19 · High-grade papillary carcinoma loses organization

Cells are less cohesive with marked nuclear atypia.

Nuclear chromatin is irregular; Nucleoli may be prominent.

Mitoses may be frequent or atypical, with loss of polarity.

Schematic

Marked atypia · loss of order · variable nuclei

Slide 20 · Low versus high grade: Discriminating features

Feature

Low-grade papillary

High-grade papillary

Architecture

Ordered, polarity retained

Disorganized, polarity lost

Cohesion

Generally cohesive

Often discohesive

Nuclei

Mild variation, occasional hyperchromasia

Marked pleomorphism; Irregular chromatin

Mitotic figures

Few; Often toward base

Frequent; Can be atypical

Slide 21 · Polarity is a microscopic clue to grade

Low-grade tumors generally retain a basal-to-luminal cellular orientation.

High-grade tumors show disordered arrangement and reduced cohesion.

An architectural observation complements—rather than replaces—nuclear assessment.

Schematic

Polarity retained · mild variation · cohesion

Slide 22 · Papillary architecture does not equal low risk

Both low-grade and high-grade carcinomas can form papillary fronds.

High-grade cytology changes the biologic interpretation of that architecture.

Extent of invasion must be assessed independently.

Schematic

Noninvasive

Invasive

Low grade

Possible

Assess separately

High grade

Possible

Possible

Grade and depth are independent descriptors

Slide 23 · Carcinoma in situ: Malignant cells confined to epithelium

CIS is noninvasive by definition despite severe cytologic atypia.

The malignant epithelium may be widespread or patchy.

A preserved basement-membrane boundary separates CIS from invasive cancer.

Schematic

Basement membrane

Cytologic atypia within urothelium

Slide 24 · CIS can be partial-thickness or pagetoid

CIS need not replace every layer of the urothelium.

Scattered malignant cells among near-normal epithelial cells are described as pagetoid spread.

Thus, a superficially bland field can contain focal malignant cytology.

Schematic

Basement membrane

Focal malignant cells in otherwise bland lining

Slide 25 · Denudation can conceal a CIS focus

Malignant urothelial cells may lose cohesiveness and detach.

Extensive shedding can leave only a sparse residual malignant lining.

The loss of surface cells complicates recognition of a flat lesion.

Schematic

Basement membrane

Cell shedding leaves a denuded surface

Slide 26 · High-grade lesions shed cells into urine

Discohesion promotes epithelial cell shedding.

This helps explain abnormal urothelial cells within urinary samples.

Cell shedding can coexist with either a visible tumor or flat carcinoma.

Schematic

Luminal tumor cells

Detachment / fragmentation

Hematuria or shed cells

Slide 27 · Grossly normal urothelium need not be normal microscopically

Remote foci of atypia or CIS near pelvic tumors.

Those abnormalities may be beyond the visible mass.

This separates the extent of visible disease from the extent of epithelial alteration.

Schematic

Renal pelvis

Ureter

Bladder

Remote atypia / CIS can be microscopic

Slide 28 · Noninvasive versus infiltrating disease

A noninvasive lesion remains superficial to the basement membrane.

Infiltrating carcinoma involves supporting tissues of the pelvic wall.

The deceptively small gross lesion may coexist with significant wall invasion.

Schematic

Noninvasive

Basement membrane intact

Invasive

Epithelial nests beneath BM

Slide 29 · Wall infiltration is common in renal-pelvis carcinoma

Pelvic and calyceal walls may already be infiltrated at discovery.

The lesion can appear limited within the lumen yet extend into the wall.

Anatomic depth is therefore essential to clinicopathologic interpretation.

Schematic

Noninvasive

Basement membrane intact

Invasive

Epithelial nests beneath BM

Slide 30 · Papillary and invasive components may coexist

Invasive carcinoma may occur adjacent to papillary carcinoma.

Invasive carcinoma may also occur with associated flat CIS.

Both the epithelial precursor and deep component are diagnostically relevant.

Schematic

Noninvasive

Basement membrane intact

Invasive

Epithelial nests beneath BM

Slide 31 · Gross morphology: Papillary, nodular, or flat

Papillary lesions protrude into the lumen as fronds.

Nodular growth may form an irregular luminal mass.

Flat CIS can be inconspicuous without a large exophytic tumor.

Schematic

Papillary

Nodular

Flat (CIS)

Schematic profiles—not photographs or scale drawings

Slide 32 · A source-described gross pelvic tumor

Robbins Fig. 20.49 depicts an opened renal pelvis.

Its caption identifies a nodular irregular neoplasm proximal to the ureter.

The gross location places the lesion in the upper urinary collecting system.

Schematic

Parenchyma

Pelvis

Ureter

Luminal mass

Slide 33 · Anatomic exposure does not specify molecular genotype

Robbins Chapter 21 presents a bladder carcinogenesis schematic.

Papillary and CIS routes are associated with differing genetic alterations in that model.

The diagram is teaching context, not a quantified mutation map for renal-pelvis tumors.

Schematic

Normal urothelium

Papillary route

Flat CIS route

RAS / FGFR3 context

TP53 / RB context

Bladder-source conceptual model, not UTUC genotyping

Slide 34 · Shared urothelial carcinogenic context

Chapter 21 implicates tobacco smoke in bladder urothelial carcinogenesis.

Industrial aryl amines are another bladder urothelial exposure category.

These bladder-derived exposure estimates are not presented as renal-pelvis-specific risks.

Schematic

Tobacco / aryl amines

Urothelial carcinogenic context

Bladder-source model

Slide 35 · Lynch syndrome: An upper-tract association

Increased renal-pelvis urothelial carcinoma incidence in Lynch syndrome.

The observation is a hereditary predisposition signal.

A pelvic urothelial carcinoma may therefore warrant attention to hereditary context.

Schematic

Lynch syndrome

Inherited cancer predisposition

Increased pelvic UTUC incidence

Slide 36 · Multifocal disease reflects a continuous epithelial field

Separate urothelial lesions can involve several urinary tract sites.

The renal pelvis, ureter, and bladder may all be involved.

Multiplicity cannot be inferred from the index mass alone.

Schematic

Renal pelvis

Ureter

Bladder

Multiple epithelial sites; Not three renal masses

Slide 37 · Pelvic carcinoma and bladder tumors often coexist

A preexisting or concomitant bladder urothelial tumor in 50% of renal-pelvis tumor cases.

This is a source-specific textbook figure, not a current individualized prediction.

The finding makes lower-tract history directly relevant.

Schematic

50%

Preexisting or concomitant bladder urothelial tumor (Robbins)

Slide 38 · Ureteral involvement adds another site of disease

Urothelial carcinoma may occur in ureter as well as pelvis and bladder.

Chapter 21 describes ureteral malignant tumors as commonly papillary.

They may cause luminal obstruction and coincide with tumors elsewhere.

Schematic

Renal pelvis

Ureter

Bladder

Multiple epithelial sites; Not three renal masses

Slide 39 · Visible multifocal tumors and microscopic field changes differ

Multiple masses represent grossly apparent multicentric lesions.

Remote atypia or CIS may be microscopic without a corresponding mass.

A complete disease map considers both types of distribution.

Schematic

Renal pelvis

Ureter

Bladder

Remote atypia / CIS can be microscopic

Slide 40 · Field involvement affects interpretation of a single specimen

A specimen may display both invasive carcinoma and flat mucosal abnormalities.

Separate foci must not be mistaken for an extension of one visible papilla alone.

Pathologic description should preserve site and pattern distinctions.

Schematic

Renal pelvis

Ureter

Bladder

Remote atypia / CIS can be microscopic

Slide 41 · Why hematuria is an early clinical clue

Pelvic tumors lie in direct contact with flowing urine.

Tumor fragmentation can produce noticeable blood in urine.

Robbins observes that this often draws attention to relatively small lesions.

Schematic

Luminal tumor cells

Detachment / fragmentation

Hematuria or shed cells

Slide 42 · A small pelvic tumor can be symptomatic

Location adjacent to the urine stream favors early bleeding.

Clinical detection may occur before a bulky mass has developed.

Small gross size does not exclude high grade or wall infiltration.

Schematic

Small ≠ superficial

Gross size cannot establish mural invasion

Slide 43 · Outflow obstruction is a second clinical mechanism

A neoplasm at the collecting-system outflow can narrow the urinary passage.

Urinary drainage is impaired proximal to the obstruction.

A large or palpable hydronephrotic collecting system may result.

Schematic

Collecting system

Pelvic / outflow lesion

Slide 44 · Hydronephrosis: Back-pressure from impaired drainage

Urine accumulates upstream of the narrowed outflow tract.

The collecting system dilates.

The enlarged system may contribute to flank pain and clinical presentation.

Schematic

Collecting system

Dilatation upstream of lesion

Slide 45 · Two pathways to presentation

Surface fragmentation and bleeding → hematuria.

Luminal obstruction → collecting-system dilatation → flank pain.

The pathways may occur independently or together.

Schematic

Tumor in pelvis

Fragmentation

Outflow narrowing

Hematuria

Hydronephrosis / pain

Slide 46 · Pain and hematuria identify consequences—not grade

Hematuria describes a luminal bleeding effect.

Flank pain can reflect outflow obstruction.

Neither symptom by itself establishes histologic grade or invasion depth.

Schematic

Noninvasive

Invasive

Low grade

Possible

Assess separately

High grade

Possible

Possible

Grade and depth are independent descriptors

Slide 47 · Kidney-region mass: Begin with the site of origin

Renal-parenchymal tumor and collecting-system urothelial tumor are different entities.

A pelvic-based lesion directs attention to urothelial morphology.

Location helps prevent application of the wrong tumor framework.

Schematic

Renal parenchyma → RCC

Collecting-system lining → UC

Slide 48 · Describe configuration, grade, and invasion separately

Configuration: Papillary, flat, nodular, or a combination.

Grade: Degree of cytologic and architectural atypia.

Invasion: Whether malignant cells have entered subepithelial tissues.

Schematic

Pattern

Grade

Invasion

Slide 49 · The visible lesion and the surrounding urothelium

Inspect the dominant mass for architecture and invasive growth.

Interpret adjacent mucosa for separate flat CIS when represented.

Record additional involved urothelial sites when identified.

Schematic

Renal pelvis

Ureter

Bladder

Remote atypia / CIS can be microscopic

Slide 50 · Bladder depth rules must not be transplanted unchanged

Muscularis propria invasion for bladder prognosis.

Renal pelvis and calyces have different wall anatomy from the bladder.

Use site-appropriate staging sources rather than assigning bladder TNM criteria to the renal pelvis.

Schematic

Bladder wall

Pelvicalyceal wall

Different site anatomy

Do not copy bladder-specific depth thresholds

Slide 51 · Renal-pelvis prognosis depends on tumor biology and spread

Low-grade noninvasive and high-grade infiltrating tumors behave differently.

Pelvic wall infiltration contributes to the guarded outlook.

Apparently limited intraluminal size can underrepresent risk.

Schematic

Tumor grade

Wall invasion

Prognostic interpretation

Slide 52 · Survival figures: Interpret with context

5-year survival of 50%–100% for low-grade noninvasive lesions.

For high-grade infiltrating tumors, it reports survival as low as 10%.

These broad literature figures are not contemporary calibrated risk estimates.

Schematic

Low-grade noninvasive

50%–100%

High-grade infiltrating

As low as 10%

Slide 53 · Grade and depth have different prognostic roles

Grade reflects the biologic aggressiveness visible in tumor cytology.

Invasion records extension beyond the epithelium.

A full interpretation requires both, not gross appearance alone.

Schematic

Tumor grade

Wall invasion

Prognostic interpretation

Slide 54 · Case 1: Hematuria and a small pelvic lesion

A patient presents with hematuria and an irregular renal-pelvis mass.

The mass is small on gross inspection.

Question: Which two pathologic assessments remain essential?

Schematic

Hematuria

Small pelvic mass

Grade + invasion?

Slide 55 · Case 1: The small size is not reassuring

Determine cytologic grade in the urothelial lesion.

Assess the pelvic wall for invasive carcinoma.

The bleeding mechanism explains presentation but not biologic stage.

Schematic

Morphology

Anatomic consequence

Integrated interpretation

Slide 56 · Case 2: Tumor plus flat mucosal atypia

A papillary renal-pelvis tumor is accompanied by atypia in remote urothelium.

Question: What precursor category may explain the remote abnormality?

Question: Why is the remote mucosa diagnostically relevant?

Schematic

Papillary lesion

Remote atypia

CIS / field?

Slide 57 · Case 2: Recognize a possible field lesion

Flat high-grade intraepithelial malignancy is termed CIS.

Remote CIS shows that disease extent may exceed the obvious mass.

Pelvis, ureter, and bladder can be involved at separate sites.

Schematic

Morphology

Anatomic consequence

Integrated interpretation

Slide 58 · Case 3: Flank pain with collecting-system dilatation

A renal-pelvis lesion coincides with hydronephrosis and flank pain.

Question: What anatomic event links the tumor to these findings?

Question: Does obstruction prove histologic high grade?

Schematic

Pelvic tumor

Hydronephrosis

Outflow obstruction?

Slide 59 · Case 3: Obstruction is the causal link

Pelvic or ureteral narrowing impairs urine outflow.

Upstream collecting-system dilatation can produce flank pain.

Obstruction alone does not establish cytologic grade.

Schematic

Morphology

Anatomic consequence

Integrated interpretation

Slide 60 · Integrated comparison of key entities

Lesion

Principal architecture

Defining observation

Papilloma

Exophytic papillary

Bland, normal-like urothelial lining

PUNLMP

Exophytic papillary

Thickened urothelium; Limited atypia

Low-grade carcinoma

Papillary

Orderly architecture; Low-grade cytology

High-grade carcinoma

Papillary ± invasive

Marked atypia and disarray

CIS

Flat mucosa

High-grade cytology without invasion

Invasive carcinoma

Wall-infiltrating

Tumor crosses epithelial boundary

Slide 61 · Consolidated pathologic reasoning

Identify collecting-system origin before classifying morphology.

Separate papillary grade, flat CIS, and wall invasion.

Relate multifocality and remote dysplasia to the urothelial field.

Use bleeding and obstruction to explain presentation—not to infer grade.

Schematic

Pattern

Grade

Invasion

Slide 62 · Primary sources and scope limits

Core text: Robbins 11th edition (2026)

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026), Chapters 20–21.

Topic section: renal-pelvis urothelial carcinoma; histologic context: urothelial neoplasms.

Images are original editable schematics; no textbook micrographs or gross specimens have been reproduced.